The physician tells a newly pregnant patient that she is having monozygotic twins.
Which of the following statements by this patient would indicate a need for further teaching by the nurse?

Choice A rationale

Essure procedure involves hysteroscopic placement of micro-inserts into the fallopian tubes, inducing a foreign body reaction and fibrosis, leading to permanent occlusion. This method is considered irreversible and suitable for women who desire no future pregnancies, which contradicts the patient's stated wish for more children in a few years. Therefore, it is inappropriate.

Choice B rationale

NuvaRing is a combined hormonal contraceptive delivering ethinyl estradiol and etonogestrel. Estrogen components in combined hormonal contraceptives can reduce milk supply in breastfeeding mothers by inhibiting prolactin secretion from the anterior pituitary gland, which is essential for lactogenesis. Thus, it is generally not recommended for breastfeeding women, especially in the early postpartum period.

Choice C rationale

Mirena, a levonorgestrel-releasing intrauterine system (LNG-IUS), primarily acts by thickening cervical mucus, inhibiting sperm motility and capacitation, and thinning the endometrial lining. As it contains only progestin and minimal systemic absorption occurs, it does not significantly impact milk production and is considered safe and effective for breastfeeding women seeking reversible contraception.

Choice D rationale

Combined oral contraceptive pills contain both estrogen and progestin. The estrogen component can suppress lactation by interfering with prolactin's action on mammary glands, potentially reducing breast milk volume and duration of breastfeeding. This makes them less ideal for a new mother who is actively breastfeeding and wishes to continue.

Choice A rationale

Oral contraceptive pills (OCPs) can be effective in managing primary dysmenorrhea by suppressing ovulation and reducing prostaglandin production, which lessens uterine contractions. However, they are not typically the *optimal initial pharmacologic therapy* for acute pain relief, but rather a long-term management strategy for persistent or severe symptoms.

Choice B rationale

Aspirin, a nonsteroidal anti-inflammatory drug (NSAID), inhibits prostaglandin synthesis and can provide some pain relief for dysmenorrhea. However, its anti-inflammatory effects are generally weaker compared to other NSAIDs, and it carries a higher risk of gastrointestinal side effects and Reye's syndrome in children, making it less optimal than other NSAIDs.

Choice C rationale

Acetaminophen is an analgesic that primarily works by inhibiting prostaglandin synthesis in the central nervous system, providing pain relief and fever reduction. While it can alleviate mild pain, it lacks the peripheral anti-inflammatory properties of NSAIDs, which are crucial for targeting the prostaglandin-mediated uterine contractions in dysmenorrhea.

Choice D rationale

Nonsteroidal anti-inflammatory drugs (NSAIDs) are considered the optimal pharmacologic therapy for primary dysmenorrhea because they effectively inhibit the production of prostaglandins. Prostaglandins are potent uterine smooth muscle stimulants and vasoconstrictors, directly causing the painful uterine contractions and ischemia associated with dysmenorrhea.